glp 1 and alcohol use disorder GLP-1 RAs may reduce alcohol-related hospitalization risk GLP-1 plus therapy can reduce

This isn't about short-term wins

Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R

A systematic review of randomised-controlled trials using locaserin noted a mean weight loss of 3.1 kg associated with its use [11] Common side effects associated with lorcaserin use include headache, nausea and dizziness [9, 15]

Safety and Long-term Effects GLP-1 agonists, including household names like Ozempic and Wegovy, are designed to mimic a naturally occurring hormone that regulates blood sugar and appetite

These results illustrate a different layer of the interaction of EEC/gut hormones, metabolism, and immunmodulation

Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes